about
BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome.Geographical Distribution of MDR1 Expression in Leishmania Isolates, from Greece and Cyprus, Measured by the Rhodamine-123 Efflux Potential of the Isolates, Using Flow Cytometry.A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasisLeishmaniases in Greece.Leishmania infantum and Toxoplasma gondii: Mixed infection of macrophages in vitro and in vivo.Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.Detection of Leishmania Infantum in red foxes (Vulpes vulpes) in Central Greece.Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 2 diabetes.TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC).Association of epithelial-to-mesenchymal transition circulating tumor cells in non-small cell lung cancer (NSCLC) molecular subgroups.Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib.Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib.Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer.Prognostic significance of the detection of peripheral blood CEACAM5mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer.Prevalent genotypes of Toxoplasma gondii in pregnant women and patients from Crete and Cyprus.Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.Leishmania donovani s.l.: evaluation of the proliferation potential of promastigotes using CFSE staining and flow cytometryPrognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancerBcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatmentLoss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon CancerMINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal CancerCharacterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatmentOral Bacteria and Intestinal Dysbiosis in Colorectal CancerCorrelation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective StudyThe Role of Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer Risk
P50
Q35075820-C123AC44-CC5F-4D5D-BBE1-70987B81F025Q36869654-A984BBFD-3279-4AB2-9875-9595C6D14A34Q37144722-762CB2D1-5F77-4F90-8BD5-091741321C32Q37287689-1998C5E6-18D5-44AB-840A-36084C937E8DQ39585614-C6DF6152-D2A1-4A50-B2AA-336EABCBC5BFQ41047711-F8849130-D2DB-41F1-A5C0-A0AE8193F166Q41328728-74B7C426-0797-44D7-88FF-AF93939403F3Q42228895-650D707D-F816-4D41-A301-AD8CC6737637Q42372003-1B430E34-3B6E-4A1D-841E-F32FB7964586Q49218297-5D88F451-2D78-438A-8F03-13BD27068627Q49357599-9EEBA462-9669-42DB-BF94-E37118DA551AQ49380125-2BE42C0C-39C3-42FF-87C3-2BFBAB0240D7Q50886105-B44A8496-64A7-4450-A7E3-8642D37571F0Q50992948-2D85E6F8-B2B9-4435-8C3D-3695F18C9F69Q54402205-C9F3D6C4-533C-437A-BD75-2B73833BD5C5Q54520951-F3ADE9F9-DEBB-4966-918E-22CB0DFA4889Q55168879-6A9103E9-F1CB-44E3-BC28-06E4C91138F0Q56771065-07EF2FBB-E976-41AA-9E39-AA4AC8E278B3Q90863961-6AF5E6A9-DB9C-4D80-BB7D-371147008F74Q91880259-4DAC892E-F68D-49DB-B2AA-EEB6E671F950Q92631585-084D32E6-A3AF-4D25-B88F-06FBFBB6EDAFQ92776310-30DBFAFA-F48C-45D6-B57A-082BB80188B3Q92853041-FB8A807D-4C86-4132-A31F-F98D051B5A0BQ92875232-7F8039CB-66C4-4481-B8AD-91EF139246EEQ93186518-EE2E4AB9-AC96-4024-83D1-14CDE0D63386Q96020126-E69584BA-DA6F-43AD-9099-EBE3704B98F7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ippokratis Messaritakis
@en
Ippokratis Messaritakis
@nl
type
label
Ippokratis Messaritakis
@en
Ippokratis Messaritakis
@nl
prefLabel
Ippokratis Messaritakis
@en
Ippokratis Messaritakis
@nl
P31
P496
0000-0003-1877-500X